These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 18202319)
1. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Johnson KA; Polewski M; Terkeltaub RA Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319 [TBL] [Abstract][Full Text] [Related]
2. A vascular bone collector: arterial calcification requires tissue-type transglutaminase. Vanbavel E; Bakker EN Circ Res; 2008 Mar; 102(5):507-9. PubMed ID: 18340013 [No Abstract] [Full Text] [Related]
3. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540 [TBL] [Abstract][Full Text] [Related]
4. Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions. Steppan J; Bergman Y; Viegas K; Armstrong D; Tan S; Wang H; Melucci S; Hori D; Park SY; Barreto SF; Isak A; Jandu S; Flavahan N; Butlin M; An SS; Avolio A; Berkowitz DE; Halushka MK; Santhanam L J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159817 [TBL] [Abstract][Full Text] [Related]
5. Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin. Beazley KE; Reckard S; Nurminsky D; Lima F; Nurminskaya M J Biol Chem; 2013 Oct; 288(43):31400-8. PubMed ID: 24036114 [TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Steitz SA; Speer MY; Curinga G; Yang HY; Haynes P; Aebersold R; Schinke T; Karsenty G; Giachelli CM Circ Res; 2001 Dec; 89(12):1147-54. PubMed ID: 11739279 [TBL] [Abstract][Full Text] [Related]
7. The redox state of transglutaminase 2 controls arterial remodeling. van den Akker J; VanBavel E; van Geel R; Matlung HL; Guvenc Tuna B; Janssen GM; van Veelen PA; Boelens WC; De Mey JG; Bakker EN PLoS One; 2011; 6(8):e23067. PubMed ID: 21901120 [TBL] [Abstract][Full Text] [Related]
8. Gene inactivation of lysyl oxidase in smooth muscle cells reduces atherosclerosis burden and plaque calcification in hyperlipidemic mice. Stoyell-Conti FF; Suresh Kumar M; Zigmond ZM; Rojas MG; Santos Falcon N; Martinez L; Vazquez-Padron RI Atherosclerosis; 2024 Oct; 397():118582. PubMed ID: 39260002 [TBL] [Abstract][Full Text] [Related]
9. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Johnson K; Polewski M; van Etten D; Terkeltaub R Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):686-91. PubMed ID: 15625282 [TBL] [Abstract][Full Text] [Related]
10. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. Cecil DL; Terkeltaub R J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305 [TBL] [Abstract][Full Text] [Related]
11. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. Kaartinen MT; Murshed M; Karsenty G; McKee MD J Histochem Cytochem; 2007 Apr; 55(4):375-86. PubMed ID: 17189522 [TBL] [Abstract][Full Text] [Related]
12. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. Johnson KA; Terkeltaub RA J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824 [TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation. McRobb LS; McGrath KCY; Tsatralis T; Liong EC; Tan JTM; Hughes G; Handelsman DJ; Heather AK Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1127-1137. PubMed ID: 28473445 [TBL] [Abstract][Full Text] [Related]
14. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification. Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065 [TBL] [Abstract][Full Text] [Related]